Where the money goes, who sees it, and what to do next.
A connected report across all three Meridian Dental Partners locations and every DentOps pillar —
Operations, Finance, Growth, Clinical, RCM and Procurement. From the first inbound lead to the collected
dollar. The story neither a PMS, a phone system, nor the accounting ledger can tell alone.
Reporting periodFeb 16 — May 16, 2026 (T90)
Trend backdropMay 2025 — May 2026
LocationsPlano · Frisco · Southlake
Practice profileMultispecialty DSO · US
Providers9 dentists · 12 RDH
Visits (T90)6,650
Revenue$13.4M
01 The Picture
Meridian is worth ~$28M today. $1.73M/yr is recoverable — and it takes the group to ~$37M.
A healthy group, not a turnaround — 26.2% EBITDA margin, revenue +12% YoY. The opportunity is
execution. Across the pillars there's $1.23M/yr of revenue you're not capturing and
$0.50M/yr of cost you're overspending; together they lift margin toward ~35% and add
+$9M of enterprise value at the group's 8.1× multiple. Below: what's working, then
the five things to act on — each with what it's worth and what to do.
$1.73M
RECOVERABLE PER YEAR
$1.23M of revenue not captured (Operations + Growth + RCM, plus Clinical net-new) and $0.50M of cost
overspent (payroll, lab, supply). No double-count — ranked, with the play, in the tabs that follow.
What's working — credit where it's due
Plano is the flagship (88/100) — 71% case acceptance, 91% schedule utilization, $610 production/chair-hr. The playbook the other two locations are benchmarked against.
Clinical quality is the floor: 0.9% complication rate, 98.5% implant survival, all specialties above benchmark — no quality discount on the valuation.
Collections are strong: 94% net collection, FFS-leaning, write-offs just 2.5%. This is a capture problem, not a bad-debt one.
Revenue +12% YoY and a profitable 26.2% EBITDA margin — the specialists (Mehta, Chen) lead production at $11–13K/day.
Demand is healthy: 612 new patients and 6,650 visits in the quarter — the funnel is full at the top; the leaks are downstream.
The five things to act on — ranked · what it is · what it's worth · what to do
1
Case acceptance is the biggest single leak. The group converts
62.6% of presented treatment (Plano 71%, Southlake just 41%) —
the CRM shows the leads, the PMS shows the diagnoses, but the conversion falls between them.
Worth $420K/yr.Do: scripted day-7/14/30 follow-up + a same-day acceptance protocol,
and re-book the $210K diagnosed-but-unscheduled backlog at near-zero acquisition cost. See Growth.
2
Southlake is sub-scale and losing margin per hour.
Schedule utilization sits at 51% and Dr. Reyes runs −$28/chair-hour
(loaded cost above revenue). Invisible on the P&L because group income covers it — it's a
utilization problem, not a clinical one. Do: lift utilization toward 70%, right-size the rota to
demand, rebalance the provider mix. See Three Locations + Provider Economics.
3
Front-of-house is leaking demand it already has.
Walkout retention 41%, missed-call rate 18%, recall recovery 15%.
The phone system shows the abandoned calls; the PMS shows the empty chairs. Worth $315K/yr.Do: book the next appointment before the patient leaves, answer & convert abandoned calls,
and work the no-future-appointment list. See Operations.
4
Not every billable dollar reaches the bank.
Denial rate 9% (target 4%), clean-claim 88%→96%,
$96K of delivered procedures unbilled, and dollars aging past 90 days.
Worth $315K/yr.Do: fix denials at the source (documentation), work the 90+ AR
before timely-filing closes it, and bill the unbilled. See RCM.
5
$0.50M of cost is overspent vs benchmark.
Payroll-to-production gap ($250K, Southlake-led), supply / GPO compliance ($150K),
and lab ($100K). It's already EBITDA, so at the 8.1× multiple it's worth
+$4M of enterprise value. Do: right-size payroll to production, consolidate vendors onto the
ACE DSN contract, and hold a lab remake SLA. See Finance + Procurement.
Plain English
Why a "connected report" matters for a multispecialty group specifically.
A multispecialty DSO runs five businesses at once — front-of-house demand, chair supply, the
treatment funnel, clinical diagnosis, and the revenue cycle — plus the cost base underneath
(payroll, lab, supply). A patient touches the practice through the CRM (the inbound enquiry), the
phone system (every callback and reschedule), the PMS (every exam, image, diagnosis and visit), the
lab (crowns and prosthetics), the clearinghouse (every claim and denial), the accounting ledger
(cost lines, payroll), and the recall book (lifetime value).
Any one system tells a partial truth. The PMS shows visits done; the phone system shows calls
answered; the ledger shows cost. None of them can tell you whether the $420K of stalled case
acceptance is stalled because the leads are weak, the front desk is overloaded, the provider's
diary is full, or the financing keeps being declined. The connected report is the only place that
question has an answer.
Think of it like an airline. The check-in counter, the gate, the bag belt and the cabin crew
each have a screen with their slice. But it's only when you put them together that you discover the flight
is leaving with 14 empty seats while 22 passengers were turned away at re-booking because nobody could see
both screens at once. That's what this report does for Meridian.
02 Headline Numbers
The trailing-90-day picture across all six pillars.
Group-level metrics for Feb 16 – May 16, 2026. Each tile is colour-coded by which DentOps pillar
owns the number. Site-level breakdown follows in Tab 04.
Finance
Production (T90)
$3.35M
+12.1% vs prior 90 days
Finance
EBITDA margin
26.2%
$3.5M on $13.4M annualised
Finance
Group valuation
~$28M
Path to ~$37M on recapture
Growth
New patients (T90)
612
Across 3 locations
Operations
Visits / procedures (T90)
6,650
9 dentists · 12 RDH
Clinical
Case acceptance
62.6%
Southlake 41% vs Plano 71%
Operations
Schedule utilization
75.4%
Range 51%–91% across sites
Operations
Walkout retention
41%
No next visit booked at checkout
Finance
Production / chair-hour
$487
Plano $610, Frisco $487, Southlake $284
RCM
Net collection rate
94%
9% first-pass denial rate
Patients
Recall compliance
71.2%
Southlake at 38% — clinical risk
Payroll
Payroll % of production
40.0%
$250K above benchmark
Payroll
Lab + materials % of production
12.0%
Frisco at 18% drags average
Growth
Unscheduled treatment
$210K
Diagnosed, not booked
RCM
Unbilled procedures
$96K
Completed, never claimed
All Pillars
Recoverable revenue (annual)
$1.73M
$1.23M revenue + $0.50M cost — Tab 09
Revenue trend — trailing 12 months
Monthly cash collected, group total
FINANCE
Production mix by service line (T90)
Share of $3.35M group production
CLINICAL
Lead source mix (T90)
Where the 1,847 inbound enquiries came from (→ 612 new patients)
GROWTH
Group P&L slice (T90)
Production · lab · provider payroll · staff + support · overhead · net
FINANCE + PAYROLL
Top-line vs gross margin · per service line · T90
The most important breakdown for a multispecialty group — which service lines actually generate the margin.
Restorative + oral surgery = 30% of procedures but 49% of total gross margin.
The CEO's question: is the mix shifting toward the high-margin specialties fast enough, and is hygiene feeding them?
Eight things the group is doing right — credited to the people doing them.
Before we get to the leaks. The basics across the group are largely sound,
which is why the recoverable revenue figures in Tab 09 are large rather than terrifying.
• WIN 01 · OPERATIONS · PLANO
Plano schedule utilization is best-in-class.
91%
Across Plano's operatories, 91% of available chair-minutes are booked and billed. Industry benchmark for a well-run multispecialty practice is 78–82%.
Credit goes to: Plano diary management & Dr. Whitfield's 6-week rolling planning rhythm.
• WIN 02 · CLINICAL
Group clinical complication rate is below benchmark.
0.9%
Across 6,650 procedures in the trailing 90 days, surgical and endodontic complications requiring intervention ran at 0.9%. Published benchmark for comparable case mix is 1.5–2.2%.
Credit goes to: clinical protocols enforced across all 3 sites, mandatory imaging before surgical cases, and standardised endo workflows.
• WIN 03 · GROWTH · PLANO
Plano's case acceptance rate is exceptional.
71%
71% of treatment plans presented at Plano convert to a scheduled, paid case. Frisco is at 56%, Southlake at 41%. Plano's "present-and-book" protocol works.
Credit goes to: Plano coordinator Sophie Bennett & the integrated finance options presented chairside.
• WIN 04 · PATIENTS · PLANO
Plano recall compliance is best-practice.
86%
86% of active patients at Plano attend their scheduled 6-month hygiene recall. At this compliance level the practice catches restorative needs early and protects lifetime value.
Credit goes to: hygienist Joanna Park's pre-book-at-checkout flow.
• WIN 05 · FINANCE
Treatment-plan close rate held at >90% across all three sites.
90.8%
426 accepted treatment plans in T90 converted to 387 started cases. Only 39 stalled between acceptance and start — well within best-practice tolerance.
Credit goes to: integrated finance providers offering 0% financing up to $12K; book-at-acceptance workflow.
• WIN 06 · CLINICAL · COSMETIC
Cosmetic & ortho is the group's highest-margin line.
60% margin
95 cosmetic and clear-aligner cases T90 generated $470K production at 60% gross margin after lab and chair time — the richest margin in the group, ahead of restorative at 54%.
Credit goes to: Dr. Reyes building the cosmetic referral pathway from hygiene; Frisco picking up the playbook.
• WIN 07 · OPERATIONS · PLANO
Same-day treatment booking at Plano is exceptional.
64%
64% of patients accepting a plan at Plano leave with the next treatment visit already on the schedule. This collapses the diagnosis-to-treatment cycle from 47 days (group avg) to 19 days at Plano.
Credit goes to: Plano's integrated chairside workflow (findings → imaging review → plan → finance → date) in one visit.
• WIN 08 · LEADERSHIP
Meridian invested in Southlake early — ahead of the numbers in this report.
2 yrs
Southlake opened May 2024. Leadership knew the ramp would be slow. The numbers below are not failure — they are diagnosis. The investment is recoverable on the 90-day plan in Tab 12.
Credit goes to: the call to open Southlake at all, in a fast-growing DFW submarket with no comparable multispecialty group within a 15-minute drive.
04 Three Sites
Three sites. Three completely different management conversations.
The group P&L hides three radically different operational stories. The same KPI set that
looks healthy at group level reveals a flagship, a growth site fighting a coordinator bottleneck,
and a site that needs urgent action this quarter.
• FLAGSHIP · HOLD
Meridian Plano
Plano TX · est. 2014 · 4 dentists · 6 chairs
88
Health score (out of 100)
Production T90$1.74M
Schedule utilization91%
Procedures T903,450
New patients T90300
Case acceptance71%
Production per chair-hr$610
Recall compliance86%
Recoverable revenue$186K
• GROWTH · UNBLOCK
Meridian Frisco
Frisco TX · est. 2020 · 3 dentists · 4 chairs
71
Health score (out of 100)
Production T90$1.12M (+28% YoY)
Schedule utilization78%
Procedures T902,210
New patients T90210
Case acceptance56%
Production per chair-hr$487
Recall compliance71%
Recoverable revenue$412K
• STRUGGLING · URGENT
Meridian Southlake
Southlake TX · est. 2024 · 2 dentists · 3 chairs
48
Health score (out of 100)
Production T90$0.49M
Schedule utilization51%
Procedures T90990
New patients T90102
Case acceptance41%
Production per chair-hr$284
Recall compliance38%
Recoverable revenue$452K
Reading the three sites together
The same KPI set tells three different stories.
Plano is operating near the ceiling of what a 6-chair multispecialty practice can do.
The 90-day move at Plano is not to push utilization higher (it's already 91%) but to
capture more value per chair-hour by shifting mix toward the high-margin specialty and cosmetic lines.
Frisco has the demand (the biggest new-patient inflow in the group) but is choking on the
operational capacity to convert it. The diagnosis is concrete: a single overloaded treatment coordinator, a lab
supplier with an above-average remake rate, and complex cases taking longer to turn around than at Plano.
All three are fixable. See Tabs 06, 08.
Southlake needs urgent intervention. The site is two years old, the clinicians are good, but
every single connected KPI is below target — call answer, case acceptance, schedule
utilization, recall compliance, production per hour. The good news: each one has a defined 30/60/90-day
action with a known revenue uplift. See Tab 12, P1 column.
Think of the three sites as a 50-meter swimming pool, a leaky garden hose, and a closed tap.
Plano is the pool — full, working hard, but bounded by physical size. Frisco is the hose —
plenty of water pressure (leads) but losing flow through a dozen small holes. Southlake is the tap —
the water is sitting on the supply side, but very little is making it through to the bucket. Each
needs a completely different fix.
05 Enquiry → Treatment
One patient. Ten steps. Six systems underneath.
Every patient walks this same journey from inbound enquiry to completed treatment and recall.
At each step, a different DentOps pillar owns the data. The drop-off at each step is shown below —
because if you don't see the drop-off, you can't fix the leak.
Patient journey funnel
Group total · trailing 90 days · Feb 16 — May 16, 2026
ALL PILLARS
Inbound enquiries GrowthWeb form · phone · referral · walk-in
1,847100%
Call answered / form actioned OperationsCoordinator picks up or follows up within SLA
1,46379.2%−384
New-patient appointment booked GrowthFirst visit in the schedule, with a date
Diagnostics & imaging complete ClinicalX-rays, charting and findings recorded
80643.6%−188
Treatment plan presented GrowthPlan with options + price + finance
68136.9%−125
Treatment plan accepted GrowthPatient said yes — either in person or by callback
42623.1%−255
Deposit / financing secured FinanceCash, card or finance package executed
38721.0%−39
Treatment started ClinicalFirst treatment visit completed
35819.4%−29 deferred
Treatment plan completed ClinicalAll planned phases delivered
31216.9%−46 in progress
Booked into recall PatientsNext hygiene recall scheduled at checkout
22712.3%−85 not booked
!
THE BIGGEST SINGLE LEAK
From 681 plans presented to 426 accepted — group case acceptance is 62.6%, losing 255 plans at this single step.
Plano converts 71%; Frisco 56%; Southlake 41%. Closing the gap to Plano's rate across Frisco and Southlake
recaptures ~$420K/yr of diagnosed treatment that is currently presented and walks away.
A further $210K sits in treatment that was accepted but never scheduled. See Tab 06 for the coordinator-bottleneck diagnosis.
Where the systems hand off
Six pillars, ten steps, one patient.
The journey above is colour-coded by which pillar owns each step. The handoffs are where things go wrong:
Step 2 → 3 (Ops → Growth): a call gets answered but the coordinator doesn't book a first visit. 384 enquiries vanish here. Step 5 → 6 (Clinical → Growth): findings are recorded but a treatment plan never goes back to the patient. 125 vanish here. Step 7 → 8 (Growth → Finance): patient says yes but the deposit or financing doesn't land. 39 vanish here. Step 10 → 11 (Clinical → Patients): treatment completed but no recall booked. 85 patients exit unprotected.
Each of these handoffs is between two pillars. Each one is invisible if you only look at one
pillar's dashboard. This is the case for DentOps.
06 Coordinator Bottleneck
The Frisco story: when you have more demand than capacity to convert it.
Meridian Frisco brought in 386 inbound enquiries this quarter — the most of any site in the group.
It converted only 56%. Three pillars together explain why, and one hire fixes it.
GROWTH · CRM
Frisco has the largest lead pipeline in the group.
Inbound leads (T90)386
% from paid (Meta + Google)64%
Marketing spend (T90)$38,420
Cost per lead$99.50
Consults booked from leads216
Lead → consult conversion56%
Stalled leads >14 days no contact170
OPERATIONS · TELEPHONY
The phone system shows when the leads bleed out.
Inbound patient calls (T90)681
Call answer rate81%
Missed calls (T90)130
Missed call hours, weekly avg8.4 hrs
Worst hour: Tue 2–4pm42% answer
Worst hour: Thu 11–1pm51% answer
Median callback time18.5 hrs
PAYROLL · STAFFING
The payroll record explains both numbers.
Coordinator FTE at Frisco1.0
Coordinators at Plano (smaller pipeline)2.0
Coordinator cost (Frisco, T90)$10,500
Coordinator workload — consults216 consults
Coordinator workload — plan follow-ups204 open plans
Coordinator workload — deposit chasing62 stages
Total open work-items per coord482
CLINICAL · THE COST OF NOT FIXING
Frisco's chairs are sitting idle while leads stall.
Schedule utilization78%
Idle chair-hours per week (group avg)28 hrs
Frisco idle chair-hours per week21 hrs
Stalled treatment plan value >30d$186,400
Lapsed lead value (no-contact >14d)$144,800
Marketing $ per converted patient$178
Marketing $ per captured case$317
Σ
THE CONNECTED DIAGNOSIS
Frisco is paying $38K/quarter for paid leads, generating
681 inbound calls, missing 130 of them (mostly Tue and Thu afternoons),
letting 170 leads go cold and 204 treatment plans stall >30 days, all because
one coordinator is doing the work of two. The chairs are sitting idle 21 hours a week
waiting for the schedule to fill. The fix is $42K/yr fully loaded for a second coordinator.
The recovered revenue at 50% conversion of the stalled pipeline is $186K in the first 90 days alone.
Frisco — call answer rate heatmap by hour and day
Last 90 days · darker = lower answer rate
OPERATIONS
Mon
Tue
Wed
Thu
Fri
9–11am
88%
85%
86%
78%
81%
11am–1pm
79%
68%
76%
51%
72%
1–2pm
61%
54%
63%
58%
66%
2–4pm
76%
42%
71%
58%
64%
4–6pm
82%
74%
84%
73%
85%
The two worst cells (Tue 2–4pm at 42%, Thu 11–1pm at 51%) are when the single coordinator is in back-to-back consults.
These two slots alone account for 68 of the 130 missed calls T90.
A second coordinator covers exactly these gaps.
07 Provider Economics
Production per chair-hour − fully-loaded cost per chair-hour = margin per provider per site.
One of the most important numbers in a multispecialty group: what is each provider's chair-hour
actually worth? Three pillars (Ops, Finance, Payroll) must join cleanly to compute it.
Meridian Southlake is currently negative.
Provider · Site
Role
Chair hrs T90 OPS
Util %
Production FIN
Prod / chair hr
Fully-loaded cost / hr PAY
Margin / hr
Dr. James Whitfield Plano · Principal · Oral surgery / implants
Principal
1,124
93%
$0.94M
$836
$298
+$538
Dr. Priya Mehta Plano · General + restorative
Associate
1,058
88%
$0.80M
$756
$262
+$494
Dr. Marcus Chen Frisco · Principal · Endodontics
Principal
1,012
82%
$0.61M
$603
$285
+$318
Dr. Sarah Okafor Frisco · General + restorative
Associate
894
74%
$0.51M
$570
$241
+$329
Dr. Elena Reyes Southlake · Principal · General + cosmetic
Principal
832
53%
$0.28M
$337
$365
−$28
Locum (Southlake rota) Southlake · 0.5 FTE
Locum
386
48%
$0.21M
$544
$420
+$124
Production providers
5.5 FTE
5,306
75%
$3.35M
$631
$302
+$329
Restorative/specialty production providers shown above (5.5 FTE). The group's 9 dentists also include part-time
general associates and hygiene-led providers whose chair-hours sit outside this margin-per-hour view.
−$28/hr
DR. REYES AT SOUTHLAKE · MARGIN PER CHAIR HOUR
Every chair hour at Meridian Southlake with the principal currently destroys $28 of margin.
Across 832 hours T90 that is $23,300 of operational loss, masked at group level by
Plano's profitability. The lever is not the clinician's skill (it's fine) —
the lever is utilization. Pushing Southlake from 53% to 70% util alone moves margin per hour from −$28 to +$138.
What "fully-loaded cost per hour" means
The cost number that nobody computes — until it's too late.
Fully-loaded cost per chair hour = base salary or day rate + payroll taxes + benefits + allocated overhead
(assistant cost, room cost, sterilization, supplies, software) + employer's portion of insurance · divided by
actually-billed chair hours.
This is the true denominator for provider profitability. A provider on a $250K package, with full
overhead allocation of $180K (typical for a multispecialty group), needs to deliver $430K of production
just to break even. At 1,500 billed chair hours/yr that is $287/hr break-even.
At 900 hours (53% util), break-even jumps to $478/hr.
It's the airline empty-seat problem. The plane's flying anyway. The crew, the fuel,
the gate fees — all sunk. Every unsold seat is pure margin loss. A dental chair is the same.
The cost is paid whether the chair is occupied or not. Meridian Southlake is currently flying with half-empty seats.
08 Case-Mix Economics
The implant-and-crown case — what it really costs, what it really earns, and why Frisco is leaking margin.
Five pillars must join cleanly to give you the answer: Clinical (case complexity), Finance (revenue and
material cost), Payroll (provider and assistant time), Operations (chair time), Patients (lifetime value from
ongoing recall). Below: the group's highest-value multispecialty case — a single implant with custom
abutment and crown — modelled at all three sites.
Model case: single implant — surgical placement, custom abutment, definitive crown, conventional financing
Avg case value at Meridian · T90 actual deliveries · numbers below are the group average; site-specific variances follow
Revenue components
Consultation + imaging fee$250
Implant surgical placement$2,400
Custom abutment$650
Definitive crown$1,650
Healing & review visits$250
Total case revenue$5,200
Direct costs CLIPAY
Implant fixture$420
Abutment & components$180
Crown lab fee$420
Provider time (3.0 hrs × loaded rate)$750
Assistant time$130
Total direct cost$1,900
Indirect & opportunity
Allocated overhead (room, sterilization)$360
Coordinator + admin time$110
Card / finance fee (2.4%)$125
Marketing attributable cost$120
Allowance for lab remake (2.3% group)$45
Total indirect$760
Case revenue
$5,200
Total cost
$2,660
Net margin / case
$2,540
Margin %
48.8%
Same case, three sites.
Component
Plano
Frisco
Southlake
Group avg
Case revenue (avg actual)
$5,350
$5,150
$4,950
$5,200
Provider time · hours per case
2.8
3.4
3.6
3.0
Provider cost per case
$700
$850
$900
$750
Lab cost per case
$390
$520
$440
$420
Lab remake rate
1.2%
4.2%
2.4%
2.3%
Total cost per case
$2,420
$2,920
$2,980
$2,660
Net margin per case
$2,930
$2,230
$1,970
$2,540
Margin %
54.8%
43.3%
39.8%
48.8%
Implant cases T90
110
70
30
210
Implant-case margin T90
$322,300
$156,100
$59,100
$537,500
Δ
FRISCO IS LEAKING $700 OF MARGIN PER IMPLANT CASE
Frisco runs 36 minutes longer per case (provider time leakage), spends $130 more on lab (different supplier),
and remakes 4.2% of crowns vs. Plano's 1.2%. At Frisco's current run rate of ~280 implant cases/yr,
bringing those three lines in line with Plano recovers $135K of annual margin.
Lab supplier review, clinical protocol benchmarking against Whitfield's technique, and a 6-week
mentoring pair-up are the three plays in the 90-day plan.
09 Recoverable Revenue
$1.73M sitting in the gaps between systems — $1.23M of revenue to capture, $0.50M of cost to recover.
Every recoverable line below comes from a cross-pillar query. None of them are visible from a single
system's dashboard. The revenue lines each have a named patient list behind the number; the cost lines
trace to the ledger and the supply contracts. Ordered by size · the 90-day plan in Tab 12 sequences them.
Lab spend & remake rate FINCLIFrisco remake rate 4.2% vs Plano 1.2% + lab supplier consolidation
$100,0005.8% · cost
How to read the stack
Every line traces to a named patient list. Nothing is theoretical.
The $96K of unbilled procedures is a specific list of completed treatments — clinical
notes show the procedure done; the clearinghouse has no matching claim. The billing team at all three sites
can be handed that list tomorrow morning and run it through the claim flow. Roughly one week of work for cash
already earned.
The $420K of stalled and unscheduled treatment is specific patients who sat in front of a
provider, said they were interested, and went home to think about it — or accepted but never got booked.
Each comes with the case value, the days since plan presentation, and the reason they hesitated (where
captured). Call list ready to print.
This is not a "future opportunity". This is money the practice has already earned
— in clinical labour, in marketing spend, in chair time, in patient trust — or already overspent,
that simply isn't captured because somebody's system doesn't talk to somebody else's system. The
connected report makes the conversation possible.
10 Recall: The Moat
The recall book is the practice's recurring-revenue moat.
A patient who attends their 6-month hygiene recall for 5 years generates an
average of $1,200 of additional high-margin hygiene + restorative revenue — and surfaces
decay and perio early, when it is cheap to treat. The book is a financial asset and a clinical
risk-mitigation asset at the same time. It is currently leaking at two of three sites.
PATIENTS · PLANO
The benchmark.
Active recall patients2,480
Compliance — 6mo recall attended86%
Compliance — 12mo recall attended81%
Avg hygiene fee / visit$148
Annual recurring rev per active patient$256
Total annual recurring rev (Plano)$635K
Decay/perio progression T12mo0.4%
PATIENTS · FRISCO
Drifting.
Active recall patients1,760
Compliance — 6mo recall attended71%
Compliance — 12mo recall attended62%
Avg hygiene fee / visit$140
Annual recurring rev per active patient$198
Total annual recurring rev (Frisco)$348K
Decay/perio progression T12mo1.1%
PATIENTS · SOUTHLAKE
The moat is open.
Active recall patients1,060
Compliance — 6mo recall attended38%
Compliance — 12mo recall attended29%
Avg hygiene fee / visit$128
Annual recurring rev per active patient$94
Total annual recurring rev (Southlake)$100K
Decay/perio progression T12mo2.4%
$73K/yr
SOUTHLAKE · RECALL REACTIVATION OPPORTUNITY
Reactivating Southlake's 304 lapsed recall patients toward Plano's 86% compliance level is worth
$73K/year of recurring revenue — and reduces the decay/perio progression rate from
2.4% to under 0.6%, catching restorative needs early instead of as emergencies
(a further cost-avoidance of roughly $16,500/year in unplanned chair time).
Why this is the moat
Multispecialty practices live or die on the recall book.
The patient who attends their 6-month hygiene recall is the closest thing a dental
practice has to a subscription business. The patient is high-trust, high-engagement,
very unlikely to switch providers, and refers an average of 1.4 new patients over
their next five years. They also represent the practice's clinical liability tail: a patient
not under recall is a patient whose decay and perio surface as emergencies — often in someone else's clinic.
Plano's 86% compliance is the result of one specific workflow: the next recall
appointment is booked at the same checkout where today's visit ends. The patient
does not leave the building without the next appointment in the schedule. Frisco has the workflow
on paper but enforcement is patchy. Southlake doesn't have the workflow at all.
This is a free 90-day fix. No new staff. No new system. Just a workflow rollout.
Lapsed recall cohort — sample callback list (top 8 by recoverable LTV)
Generated from cross-query: dim_patients.last_visit_date + fact_appointments.last_attended + fact_treatment_codes.recall_due
PATIENTS · SOUTHLAKE
Patient-3284Crown + perio maintenance · last attended Dec 2024$3,800 LTV17mo lapsed
Patient-2917Implant + 2 restorations · last attended Mar 2025$2,400 LTV14mo lapsed
Patient-4101Anterior crown + hygiene · never returned$1,800 LTV18mo lapsed
Patient-35522 fillings + recall · cancelled 1 recall$2,200 LTV9mo lapsed
Patient-4288Root canal + crown · last attended Feb 2025$3,600 LTV15mo lapsed
Patient-37442 premolar fillings · never returned$2,000 LTV18mo lapsed
Patient-4012Single molar crown · cancelled 6mo recall$1,600 LTV10mo lapsed
Patient-3198Bridge + perio maintenance · last attended Nov 2024$2,900 LTV17mo lapsed
Full list of 304 patients exportable to CSV for outbound campaign. PII masked here per DentOps security policy.
11 Site Deep Dive
All three sites, side by side, on every KPI that matters for a multispecialty group.
One page. 36 KPIs × 3 sites. Where each pillar owns each row. Outlier cells flagged.
Use this as the management agenda — one line item per row.
KPI
Pillar
Plano
Frisco
Southlake
Group / Target
Growth · lead pipeline
Inbound enquiries T90
GRO
412
386
248
1,046 / target 1,200
Lead source: paid digital %
GRO
42%
64%
71%
55% group
Lead source: referral %
GRO
38%
22%
14%
26% group
Cost per lead
GRO
$68
$99.50
$118
$89 group
Lead → consult conversion
GRO
74%
56%
41%
59% group / 70% target
Stalled leads >14 days no contact
GRO
28
170
98
296
Operations · telephony & diary
Inbound call volume T90
OPS
1,184
681
512
2,377
Call answer rate
OPS
92%
81%
51%
79% group
Missed callbacks T90
OPS
95
130
271
496 (out: 68 recovered)
Schedule utilization
OPS
91%
78%
51%
75% / 78% target
White space hrs/week
OPS
9.4
21.0
38.4
22.9 group
FTA rate
OPS
4.8%
8.6%
12.4%
8.1% group
Same-day-conversion at consult
OPS
64%
48%
28%
49% group
Clinical · procedures & outcomes
New-patient exams
CLI
412
386
196
994
Diagnostic imaging studies
CLI
348
312
146
806
Implant cases
CLI
110
70
30
210
Crown & bridge units
CLI
520
410
180
1,110
Endo cases
CLI
168
132
110
410
Complication rate
CLI
0.7%
0.8%
1.9%
0.9% group
Treatment completion rate
CLI
99.2%
98.6%
97.1%
98.8% group
Lab remake rate
CLI
1.2%
4.2%
2.4%
2.3% group
Crown delivery TAT (days)
CLI
12
14
18
14 group
Finance
Production T90
FIN
$1.74M
$1.12M
$0.49M
$3.35M
Production per chair-hour
FIN
$610
$487
$284
$487 / $450 target
Avg treatment-plan value
FIN
$1,850
$1,620
$1,340
$1,700 group
Case acceptance rate
FIN
71%
56%
41%
62.6% group
Financing take-up
FIN
58%
66%
71%
63% group
Net collection rate
FIN
96%
94%
90%
94% group
Unbilled procedures >30d
FIN
8
19
11
38 / target < 5
Patients
Active recall patients
PAT
2,480
1,760
1,060
5,300
Recall compliance
PAT
86%
71%
38%
71.2% group
Lapsed cohort >9mo
PAT
62
166
304
532 total
Recurring rev / active pt / yr
PAT
$256
$198
$94
$204 group
Decay/perio progression T12mo
PAT
0.4%
1.1%
2.4%
1.1% group
Referral patients (T90)
PAT
157
86
35
278
Payroll & cost
Dentist FTE
PAY
4.0
3.0
2.0
9.0
Coordinator FTE
PAY
2.0
1.0
0.5
3.5 / target 5.0
Provider payroll % of production
PAY
22.4%
26.1%
31.8%
25.3% group
Lab + materials % of production
PAY
11.0%
14.0%
13.0%
12.0% group
Margin per chair-hour
PAY
+$516
+$323
+$48
+$329 group
12 The 90-Day Plan
Sequenced actions. Early wins fund the harder work.
Ten action cards across three 30-day phases. Each card names which pillars supply the data and
which pillar owns the work. Recoverable value $1.73M across the full sequence; $414K
is bankable inside the first 30 days.
PHASE 1
Days 1–30 · Stop the bleed
$414K bankable
Run the unbilled-procedure recovery campaign at all 3 sites. 38 claims, 7 days of billing-team work, $96K cash. CLIFIN
Print Southlake's 304-name lapsed-recall callback list. Hygienist + front desk work a list of 25 patients/day; reactivation conversion expected 30%. $73K/yr recurring + clinical risk reduction. PATCLI
Hire 2nd coordinator at Frisco. Job posted day 1, hired by day 21. Cost $42K/yr loaded. PAYGRO
Implement the "next-recall-at-checkout" flow at Frisco + Southlake. Workflow rollout, training, daily compliance check by manager. $58K/yr recurring uplift in Y1. PATOPS
Block Tue 2–4pm and Thu 11–1pm at Frisco as call-protected slots until 2nd coordinator starts. ~$28K recovered missed-call value in interim. OPS
PHASE 2
Days 31–60 · Capture momentum
$412K addressable
Run the 204-name stalled case-plan recovery at Frisco with the new 2nd coordinator. Scripted follow-up at days 7, 14, 30. Expected conversion 35% — $144K of stalled value recovered. GROCLI
Review & switch Frisco's lab supplier. 4.2% remake rate is double group average; commercial review with current supplier + RFP to two alternates. $58K/yr direct cost saving. CLIFIN
Pair-up: Dr. Whitfield mentors Dr. Chen on complex-case efficiency for 6 weeks. Target: bring per-case chair time from 8.9 to 8.3 hours. $46K/yr margin uplift on Frisco specialty cases.CLIPAY
Activate the 428-name missed-callback campaign (Southlake-weighted) via outbound dialler. $186K recoverable lead value at 25% conversion. OPSGRO
PHASE 3
Days 61–90 · Build the system
Structural — lasting
Hire 0.5 FTE additional coordinator at Southlake (combined with marketing analyst role). Funds Phase 1 momentum. PAYGRO
Re-pitch Southlake's Google Ads + Meta campaigns with the new Phase 1 case studies and reduced cost-per-lead target (current $118, target $82). +72 leads/month at lower CAC.GRO
Roll out the Plano "same-day-conversion at consult" protocol to Frisco + Southlake. Training in week 9; first cohort runs week 10–12. Target: lift Frisco acceptance from 56% to 65%, Southlake from 41% to 55%. $220K annualised value.GROOPSCLI
Build the integrated recall + clinical-risk-tracking workflow so Southlake's decay/perio progression is monitored monthly, not annually. CLIPAT
Re-baseline the report. By day 90, re-run this connected report and measure realised vs forecast on each line. Adjust the next quarter's plan accordingly. OPSFIN
Priority action cards — the four critical ones.
• DO FIRST · P1 · WEEK 1
Unbilled procedure recovery — group-wide
38 completed procedures have no claim submitted. Clinical notes show procedure complete; the clearinghouse has no
matching claim raised. Per-site: Plano 8, Frisco 19, Southlake 11. Total recoverable: $96,000 cash,
executable in 7 days.
WHAT TO ACTUALLY DO
Print the claim list per site. The billing team runs the claim-submission flow Monday morning of week 1.
Practice manager signs off by Friday. By end of week 2, cash should be 80% landed.
CLI · DATAFIN · ACTIONOPS · WORKFLOW
• DO FIRST · P1 · WEEK 1
Frisco coordinator hire
One overloaded coordinator is the upstream cause of: 130 missed inbound calls, 170 cold leads, 204 stalled treatment plans,
21 idle chair-hours/week. Cost to fix: $42K/yr loaded. Time to fix: 21 days from job ad to start.
Lookback ROI: 4.4× in the first 90 days.
WHAT TO ACTUALLY DO
Frisco practice manager posts ad week 1. Interview pipeline w2–w3. Offer + start w4.
90-day check-in tied to Tab 06 metrics (call answer rate, stalled plan count).
PAY · HIREOPS · CAPACITYGRO · OUTCOME
• DO SOON · P2 · WEEK 5
Frisco lab supplier review & switch
Frisco remake rate is 4.2% vs group average 2.3% and Plano 1.2%. Two suppliers have submitted
comparison quotes that come in $130/case lower with published remake rate <2%. Switch is reversible.
$58K/yr direct cost saving + reduced clinical re-work + faster crown TAT.
WHAT TO ACTUALLY DO
Group clinical lead + Frisco principal run a 4-week trial with Supplier B on the next 8 crown & bridge cases.
Compare remake, fit, aesthetic outcome, TAT. Decision gate at week 8.
CLI · PROTOCOLFIN · COSTPAY · OUTCOME
• DO SOON · P2 · WEEK 4
Southlake recall reactivation
304 lapsed recall patients at Southlake. Clinical risk (decay/perio progression already 2.4% vs group 1.1%) +
recurring revenue moat. Reactivation campaign: SMS + phone + targeted incentive (free first review).
$73K/yr recurring + $16.5K/yr clinical cost avoidance.
WHAT TO ACTUALLY DO
Southlake hygienist owns the list. 25 calls/day × 12 working days. SMS reminder + complimentary first review offer.
Target reactivation: 30% (91 patients). Tracking weekly in the connected dashboard.
PAT · DATACLI · OUTCOMEFIN · VALUE
Σ
FORECAST AT END OF 90 DAYS
If Phase 1 and Phase 2 are executed in full: group quarterly production moves from $3.35M to
$3.80M (+13.4%), group schedule utilization moves from 75% to 81%, Southlake
margin per chair-hour moves from −$28 to +$138 (positive for the first time),
and the recoverable stack rebuilds to a new baseline of $420K
(reflecting steady-state operational leakage at the size we've grown into).
13 The Service-Mix Story
11% of procedures. 50% of margin. The service-mix question the practice should ask every quarter.
A multispecialty group's P&L is not built from "visits." It's built from six service lines, each with materially different
revenue, cost, and margin profiles. The CEO's question — "what's top-line vs gross margin per service line?" — is the single most important strategic frame.
This tab answers it.
$2,970 / case
★ HIGHEST-MARGIN LINE · COSMETIC & ORTHO
60% margin · $282K margin contribution from 95 cases T90.
Cosmetic and clear-aligner cases earn the practice $680 / chair-hour — the richest line in the group —
and feed the recall book and the referral engine on the way through.
1
The 80/20: the three specialty lines — endo, oral surgery & implants, cosmetic & ortho — are
11% of procedures but 50% of total gross margin. Restorative is the engine
($517K, 27% of margin); hygiene is the feeder. The growth lever is not "more visits" — it's more of the right work.
2
Cosmetic & ortho is the unlock. 60% margin (highest in the group), $2,970 contribution per case,
and it feeds directly off the hygiene base — the patient is already in the chair. Plano runs 55 cases T90, Frisco 30,
Southlake just 10. The capability and marketing build at Southlake is the lever.
3
Exams and hygiene look like low margin — but that's the wrong lens. Exams sit at 45% margin and hygiene
at 68%, yet hygiene is the single most valuable line in the group because of what it feeds: every recall visit is a chance to
diagnose restorative and specialty work. Protect hygiene capacity; it is the top of the funnel.
4
The mix-shift math: every 1% of production shifted from exams/hygiene-only toward restorative + specialty is worth
~$22K/qtr of incremental gross margin at the current run-rate.
Lifting Southlake's specialty share toward Plano's alone unlocks $80K+/qtr without adding chairs, payroll or marketing spend.
The full service-line economics matrix
Six service lines · T90 actuals · procedures, top-line, direct cost, gross margin $, margin %, contribution %, and $ per chair-hour.
Top-line sums to the $3.35M group production; gross margin sums to $1.91M (56.9%). This is the same mix shown on the Headline Numbers tab, broken out in full.
Service line
Procedures T90
Avg $
Top-line $
Direct cost $
Gross margin $
Margin %
% total margin
$/chair hr
Hygiene & perio
3,020
$155
$468K
$150K
$318K
68%
17%
$185
Restorative(fillings / crowns / bridges)
1,790
$535
$957K
$440K
$517K
54%
27%
$560
Endodontics
400
$1,180
$472K
$198K
$274K
58%
14%
$640
Oral surgery & implants
210
$3,450
$724K
$326K
$398K
55%
21%
$590
Cosmetic & ortho(veneers / clear aligners)
95
$4,950
$470K
$188K
$282K
★ 60%
15%
$680
Exams & diagnostics(new-patient exams / imaging)
1,135
$230
$260K
$143K
$117K
45%
6%
$230
Group total
6,650
$504
$3.35M
$1.45M
$1.91M
56.9%
100%
$487
Σ
THE CONCENTRATION INSIGHT
Endo + oral surgery & implants + cosmetic & ortho combined: 705 procedures (11% of volume) generating $954K of margin (50% of margin contribution).
A 1-point shift of production into these lines is worth ~$22K/qtr.
The practice already has the clinical capability and the lab relationships — the constraint is upstream demand generation
(Growth pillar lead-source quality) and downstream capability build at Southlake.
Service mix × site — where each line actually happens
Each site indexes toward a different mix. Plano is the premium-mix site (heavy on specialty + cosmetic).
Frisco is balanced. Southlake leans on hygiene, exams and basic restorative,
with very little specialty or cosmetic — which structurally caps its production-per-chair-hour at $284 vs Plano's $610.
Service line
Plano cases / margin
Frisco cases / margin
Southlake cases / margin
Group margin
Hygiene & perio
1,180 · $140K
1,120 · $110K
720 · $68K
$318K
Restorative
760 · $270K
660 · $175K
370 · $72K
$517K
Endodontics
168 · $130K
132 · $95K
100 · $49K
$274K
Oral surgery & implants
110 · $225K
70 · $128K
30 · $45K
$398K
Cosmetic & ortho
55 · $180K
30 · $80K
10 · $22K
$282K
Exams & diagnostics
480 · $55K
410 · $42K
245 · $20K
$117K
Site margin total (% of group margin)
2,753 cases · $1.00M (52%)
2,422 cases · $630K (33%)
1,475 cases · $276K (15%)
$1.91M
Why this matters for the next 90 days
The mix shift is the highest-leverage move in the practice.
Hiring a coordinator costs $42K/yr. Switching a lab supplier saves $58K/yr. Reactivating 304 lapsed patients earns $73K/yr recurring.
These are good moves — but they are all operational levers.
Mix shift is a strategic lever, not an operational one. Lifting Southlake's specialty + cosmetic share toward Plano's delivers
+$80K of incremental gross margin per quarter with no new payroll, no new chairs, no new marketing spend.
Just better case selection by the treatment coordinators and case-acceptance training that surfaces the right treatment
for each patient's clinical situation (and for the practice's economics).
Think of it like a wine list. Every restaurant sells house wine. The margin difference between selling 100 bottles of house wine
and selling 80 house + 20 reserve list is what separates a fine-dining restaurant from a chain. Meridian's reserve list is the specialty & cosmetic book.
Right now Plano runs it, Frisco dabbles, Southlake barely opens it. That's the strategic question for FY27.